Cargando...
How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients
Background: The literature suggests that medical oncologists differ on how they use the Oncotype DX (ODX) genomic assay for making decisions about systemic therapy in breast cancer patients. Given the emergence of data supporting the use of genomic profiling for the prognosis and predicting benefit...
Guardado en:
| Publicado en: | Curr Oncol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7985759/ https://ncbi.nlm.nih.gov/pubmed/33557029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28010077 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|